Home › Research › Brain scans and imaging
Trajectories of CSF and plasma MTBR‐tau 243 and phosphorylated‐tau species across the Alzheimer's disease continuum
Lyduine Eisa Collij, Gemma Salvadó, Kanta Horie, Nicolas R. Barthélemy, Tobey J. Betthauser, Olof T. Strandberg, Ruben A Smith, Sebastian Palmqvist et al.. Alzheimer s & Dementia, 2025-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Result The CSF and plasma cohorts were on average 71.4(±8.5) and 72.2 (±9.3) years of age, 49.1%/50.8% was female, and 263/453 (0.59%/51.8%) were cognitively impaired, respectively. In both CSF and plasma, only %p‐tau217 changed early, with significantly increased levels just prior to Aβ‐PET positivity (Figure 1A‐D, Figure 2A/B). Changes in CSF and plasma %p‐tau205 were closely associated with tau‐PET positivity onset (Figure 1H, Figure 2C/D). MTBR‐tau243 trajectories, especially in plasma, were closely associated with trajectories of cortical tau‐PET burden (Figure 1C, Figure 2C).
What this study adds
Evidence grade: Low
The record lists 97 participants. This study describes how CSF and plasma tau markers change across the Alzheimer's continuum, with %p-tau217 changing early before Aβ-PET positivity and %p-tau205 and MTBR-tau243 tracking later tau-PET changes. Reported effect size: 49.1%; 50.8%; 0.59%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Collij, L. E., Salvadó, G., Horie, K., Barthélemy, N. R., Betthauser, T. J., Strandberg, O. T., et al. (2025). Trajectories of CSF and plasma MTBR‐tau 243 and phosphorylated‐tau species across the Alzheimer's disease continuum. Alzheimer s & Dementia. https://doi.org/10.1002/alz70856_098557
Vancouver
Collij LE, Salvadó G, Horie K, Barthélemy NR, Betthauser TJ, Strandberg OT, et al. Trajectories of CSF and plasma MTBR‐tau 243 and phosphorylated‐tau species across the Alzheimer's disease continuum. Alzheimer s & Dementia. 2025. doi:10.1002/alz70856_098557. PMID: 41443949.
BibTeX
@article{collij2025-41443949,
author = {Collij, Lyduine Eisa and Salvadó, Gemma and Horie, Kanta and Barthélemy, Nicolas R. and Betthauser, Tobey J. and Strandberg, Olof T. and Smith, Ruben A and Palmqvist, Sebastian and others},
title = {{Trajectories of CSF and plasma MTBR‐tau 243 and phosphorylated‐tau species across the Alzheimer's disease continuum}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70856_098557},
pmid = {41443949},
url = {https://doi.org/10.1002/alz70856_098557}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Result The CSF and plasma cohorts were on average 71.4(±8.5) and 72.2 (±9.3) years of age, 49.1%/50.8% was female, and 263/453 (0.59%/51.8%) were cognitively impaired, respectively.
- In both CSF and plasma, only %p‐tau217 changed early, with significantly increased levels just prior to Aβ‐PET positivity (Figure 1A‐D, Figure 2A/B).
- Changes in CSF and plasma %p‐tau205 were closely associated with tau‐PET positivity onset (Figure 1H, Figure 2C/D).
- MTBR‐tau243 trajectories, especially in plasma, were closely associated with trajectories of cortical tau‐PET burden (Figure 1C, Figure 2C).
Why it matters
This study describes how CSF and plasma tau markers change across the Alzheimer's continuum, with %p-tau217 changing early before Aβ-PET positivity and %p-tau205 and MTBR-tau243 tracking later tau-PET changes. These are biomarker trajectories for detection and monitoring, not treatments, cures, or prevention.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Participants97
- Effect size49.1%; 50.8%; 0.59%
- Evidence strengthLow
How this study scored 45/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 97 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Oskar Hansson: h-index 148 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Washington University in St. Louis: institution h-index 1,962 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 10 institution(s) in 4 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41443949) |
| Free to read | 2 / 2 | Free to read |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70856_098557
- PubMed: 41443949
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Brain scans and imaging from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.